Clinical trials sponsored by Boston Scientific Corporation

Phase breakdown

Conditions studied

Recruiting trials led by Boston Scientific Corporation

• Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
  NCT07444320 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
  NCT07575269 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• FARAPULSE™ Pulsed Field Ablation System
  NCT06762717 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Feasibility Study of the FARAFLEX Mapping and PFA System
  NCT06510556 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• OPTION-EMEA Clinical Trial
  NCT07349121 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
  NCT07195708 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
  NCT07106970 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
  NCT02071134 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 86 locations
• Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
  NCT06735534 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 41 locations
• Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
  NCT07069738 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 40 locations
• Safety and Effectiveness of Orbera365™ Intragastric Balloon System
  NCT07062094 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• TheraSphere Japan Pre-Market Study
  NCT07377487 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• WATCHMAN FLX Pro European Registry
  NCT07262255 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
  NCT06686485 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 37 locations

Common questions

How many trials is Boston Scientific Corporation recruiting for?

Boston Scientific Corporation is the lead sponsor of 14 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.